Publications list for Honorary Associate Professor Qihan Dong

2013 | 2012 | 2010 | 2009 | 2008


  • Xie, C., Powell, C., Yao, M., Wu, J., Dong, Q. (2013), Ubiquitin-conjugating enzyme E2C: A potential cancer biomarker. The International Journal of Biochemistry & Cell Biology. 47C, 113-117. [Abstract]
  • Garbutcheon-Singh, K., Myers, S., Harper, B., Ng, N., Dong, Q., Xie, C., Aldrich-Wright, J. (2013), The effects of 56MESS on mitochondrial and cytoskeletal proteins and the cell cycle in MDCK cells. Metallomics. 5(8), 1061-1067. [Abstract]
  • Ghalayini, M., Dong, Q., Richardson, D., Assinder, S. (2013), Proteolytic cleavage and truncation of NDRG1 in human prostate cancer cells, but not normal prostate epithelial cells. Bioscience Reports. 33(3), e00042. [Abstract]
  • Hua, S., Yao, M., Vignarajan, S., Witting, P., Hejazi, L., Gong, Z., Teng, Y., Niknami, M., Assinder, S., Richardson, D., Dong, Q. (2013), Cytosolic phospholipase A2alpha sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells. Biochimica et Biophysica Acta. 1831(6), 1146-1157. [Abstract]
  • Dixon, K., Lui, G., Kovacevic, Z., Zhang, D., Yao, M., Chen, Z., Dong, Q., Assinder, S., Richardson, D. (2013), Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells. British Journal of Cancer. 108(2), 409-419. [Abstract]
  • Xiao, W., Graham, P., Hao, J., Chang, L., Ni, J., Power, C., Dong, Q., Kearsley, J., Li, Y. (2013), Combination Therapy with the Histone Deacetylase Inhibitor LBH589 and Radiation Is an Effective Regimen for Prostate Cancer Cells. PloS One. 8(8), e74253. [Abstract]


  • Yao, M., Xie, C., Constantine, M., Hua, S., Hambly, B., Jardine, G., Sved, P., Dong, Q. (2012), How can food extracts consumed in the Mediterranean and East Asia suppress prostate cancer proliferation?. British Journal of Nutrition. 108(3), 424-430. [Abstract]


  • Niknami, M., Vignarajan, S., Yao, M., Hua, S., Witting, P., Kita, Y., Shimizu, T., Sved, P., Patel, M., Dong, Q. (2010), Decrease in expression or activity of cytosolic phospholipase A(2)alpha increases cyclooxygenase-1 action: A cross-talk between key enzymes in arachidonic acid pathway in prostate cancer cells. Biochimica et Biophysica Acta. 1801(7), 731-737. [Abstract]
  • Assinder, S., Au, E., Dong, Q., Winnick, C. (2010), A novel splice variant of the beta-tropomyosin (TPM2) gene in prostate cancer. Molecular Carcinogenesis. 49(6), 525-531. [Abstract]
  • Scott, K., Sajinovic, M., Hein, J., Nixdorf, S., Galettis, P., Liauw, W., de Souza, P., Dong, Q., Graham, G., Russell, P. (2010), Emerging roles for phospholipase A(2) enzymes in cancer. Biochimie. 92(6), 601-10. [Abstract]
  • Singh, J., Xie, C., Yao, M., Hua, S., Vignarajan, S., Jardine, G., Hambly, B., Sved, P., Dong, Q. (2010), Food extracts consumed in Mediterranean countries and East Asia reduce protein concentrations of androgen receptor, phospho-protein kinase B, and phospho-cytosolic phospholipase A(2)alpha in human prostate cancer cells. Journal of Nutrition. 140(4), 786-791. [Abstract]
  • Yao, M., Taylor, R., Richards, M., Sved, P., Wong, J., Eisinger, D., Xie, C., Salomon, R., Risbridger, G., Dong, Q. (2010), Prostate-Regenerating Capacity of Cultured Human Adult Prostate Epithelial Cells. Cells, Tissues, Organs. 191(3), 203-212. [Abstract]
  • Young, L., Dong, Q. (2010), Targeted Amplification of Mutant Strands for Efficient Site-Directed Mutagenesis and Mutant Screening. In: Methods in Molecular Biology: In Vitro Mutagenesis Protocols. (pp.147-155).United States: Humana Press.


  • Niknami, M., Dong, Q., Witting, P. (2009), Pitfalls in the use of arachidonic acid oxidation products to assign lipoxygenase activity in cancer cells. Free Radical Research. 43(10), 951-956. [Abstract]
  • Richards, A., McGeechan, K., Niknam, M., Salomon, R., Kurek, C., Dong, Q., Patel, M. (2009), Prolonging androgen sensitivity in prostate cancer - a role for COX inhibitors?. ANZ Journal of Surgery. 79(9), 641-647. [Abstract]
  • Salomon, R., Young, L., Macleod, D., Yu, X., Dong, Q. (2009), Probasin promoter-driven expression of ID1 is not sufficient for carcinogenesis in rodent prostate. Journal of Histochemistry and Cytochemistry. 57(6), 599-604. [Abstract]
  • Niknami, M., Patel, M., Witting, P., Dong, Q. (2009), Molecules in focus: Cytosolic phospholipase A(2)-alpha. The International Journal of Biochemistry & Cell Biology. 41(5), 994-997. [Abstract]
  • Assinder, S., Dong, Q., Mangs, H., Richardson, D. (2009), Pharmacological Targeting of the Integrated AKT, PTEN and TGF-{beta} Pathways in Prostate Cancer. Molecular Pharmacology. 75(3), 429-436. [Abstract]
  • Assinder, S., Dong, Q., Kovacevic, Z., Richardson, D. (2009), The TGF-beta, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer. Biochemical Journal. 417(2), 411-421. [Abstract]


  • Patel, M., Singh, J., Niknami, M., Kurek, C., Yao, M., Lu, S., Maclean, F., King, N., Gelb, M., Scott, K., Russell, P., Boulas, J., Dong, Q. (2008), Cytosolic Phospholipase A2-{alpha}: A Potential Therapeutic Target for Prostate Cancer. Clinical Cancer Research. 14(24), 8070-8079. [Abstract]
  • Patel, M., Kurek, C., Dong, Q. (2008), The arachidonic acid pathway and its role in prostate cancer development and progression. The Journal of Urology. 179(5), 1668-1675. [Abstract]
  • Nikinami, M., Patel, M., Witting, P., Dong, Q. (2008), Aberrant activation of arachidonic acid and eicosanoid pathways-targets for treating prostate cancer. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery. 2, 9-15.